drug
Brilinta
Marketedupdated 4mo agoby AstraZeneca Pharmaceuticals LP
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4all catalysts(0)
nothing on the calendar yet
Trials studying Brilinta
- phase3Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
- N/AThromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization
- phase1Comparative Bioavailability Study Between Ticagrelor and ASA Administered Individually or in Combination.
- phase1Catequentinib Hydrochloride (AL3818) Drug-Drug Interaction Study in Healthy Volunteers
- phase3DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial Injury
- phase3TADCLOT- a Double Blind Randomized Controlled Trial
- phase1A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy Subjects
- phase1A Study to Investigate the Effect of Oral Ticagrelor on the Pharmacokinetics of Oral Rosuvastatin When Given in Healthy Participants
News(1)
- 10 clinical trials to watch in the second half of 2026The biotechnology sector’s upswing accelerated in the first half. Positive results from anticipated trials in lung cancer, Alzheimer’s and multiple autoimmune conditions could add to the momentum.biopharma_dive · 2mo ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that